Core Viewpoint - Monteverde & Associates PC is investigating Royal Gold, Inc. regarding its merger with Sandstorm Gold Ltd, questioning the fairness of the deal where existing Royal Gold shareholders will own approximately 77% of the combined company [1]. Group 1: Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has recovered millions for shareholders [1]. - The firm is headquartered in the Empire State Building, New York City, and specializes in class action securities litigation [2]. Group 2: Merger Details - The proposed merger between Royal Gold, Inc. and Sandstorm Gold Ltd will result in existing Royal Gold shareholders owning about 77% of the new entity [1].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased DoubleVerify Holdings, Inc. common stock during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought DoubleVerify common stock between November 10, 2023, and February 27, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by July 21, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that DoubleVerify made false and misleading statements regarding its business operations, including the shift of customers' ad spending to closed platforms where DoubleVerify's capabilities were limited [5]. - It is claimed that DoubleVerify's high-margin advertising optimization services faced significant challenges in monetization due to the high costs and time required for technology development on closed platforms [5]. - The lawsuit also states that DoubleVerify systematically overbilled customers for ad impressions served to declared bots, and that its risk disclosures were materially misleading [5].

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of 3D Systems Corporation (NYSE: DDD) between August 13, 2024 and May 12, 2025, both dates inclusive (the “Class Period”), of the important August 12, 2025 lead plaintiff deadline. SO WHAT: If you purchased 3D Systems securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Elevance Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The class action lawsuit has been filed against Elevance Health, Inc. for allegedly making false or misleading statements regarding the Medicaid redetermination process and its impact on the company's financial guidance [4]. - Investors who purchased Elevance common stock between April 18, 2024, and October 16, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][4]. - The deadline to move the Court to serve as lead plaintiff is July 11, 2025, and a lead plaintiff acts on behalf of other class members in directing the litigation [2]. Group 2: Allegations Against Elevance Health - The lawsuit claims that Elevance Health misrepresented its monitoring of cost trends associated with the Medicaid redetermination process, leading investors to believe that premium rates were sufficient to address the risk profiles of Medicaid patients [4]. - It is alleged that the company failed to disclose that the acuity and utilization of its Medicaid members were rising significantly, as healthier members were being removed from Medicaid programs [4]. - The misrepresentation of financial guidance and rate negotiations with states is said to have caused investor damages when the true situation was revealed [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen has been recognized as a Titan of Plaintiffs' Bar by Law360, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3].

Core Viewpoint - Compass Diversified (NYSE: CODI) has warned investors not to rely on its previously issued financial statements for fiscal years ending December 31, 2022 and 2023 due to expanded accounting irregularities [1][5]. Group 1: Financial Irregularities - The company disclosed that accounting irregularities at its subsidiary, Lugano Holding, affected financial statements for fiscal years 2022, 2023, and 2024, necessitating restatements [4][5]. - The irregularities include violations of applicable accounting rules and industry practices concerning financing, accounting, and inventory procedures [9]. Group 2: Legal Actions - Following the announcement of accounting issues, Compass Diversified is facing multiple class-action lawsuits, with the lead plaintiff's deadline set for July 8, 2025 [3][4]. - The amended complaint in the case Moreno v. Compass Group Diversified Holdings LLC seeks to represent investors who purchased shares from February 24, 2022, to May 7, 2025 [3][4]. Group 3: Market Reaction - The market reacted severely to the news, with Compass Diversified's stock price dropping by over 62% following the disclosure of the accounting irregularities [7]. Group 4: Investigations - Hagens Berman, a national investor rights law firm, is conducting an investigation into potential securities violations by Compass Diversified [8][10]. - The firm's investigation highlights a lack of effective internal controls over financial reporting, leading to materially misstated financial results [9].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of DoubleVerify Holdings, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased DoubleVerify common stock between November 10, 2023, and February 27, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by July 21, 2025 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm for more information [6]. Group 2: Case Allegations - The lawsuit alleges that DoubleVerify made false and misleading statements regarding its business operations, including the shift of customers' ad spending to closed platforms where DoubleVerify's capabilities were limited [5]. - It is claimed that the company overbilled customers for ad impressions served to declared bots and that its risk disclosures were materially false and misleading [5]. - The lawsuit asserts that competitors were better positioned to incorporate AI into their offerings, adversely impacting DoubleVerify's profits and competitive standing [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen has been recognized as a Titan of Plaintiffs' Bar by Law360, highlighting the firm's expertise in this area [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of DoubleVerify Holdings, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought DoubleVerify common stock between November 10, 2023, and February 27, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by July 21, 2025 [3]. Group 2: Case Allegations - The lawsuit alleges that DoubleVerify made false and misleading statements regarding its business operations, including the shift of customer ad spending to closed platforms where its capabilities were limited [5]. - It is claimed that DoubleVerify's high-margin Activation Services faced significant challenges in monetization due to the high costs and time required for technology development on closed platforms [5]. - The lawsuit also states that DoubleVerify systematically overbilled customers for ad impressions served to declared bots, and its risk disclosures were materially misleading [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering hundreds of millions for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, including a notable settlement against a Chinese company [4].

Core Viewpoint - A class action lawsuit has been filed against Apple Inc. for allegedly making false and misleading statements regarding the integration of advanced AI-based features into its devices, which may have impacted investor decisions and the company's financial prospects [1][5]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of purchasers of Apple securities between June 10, 2024, and June 9, 2025 [1]. - The lawsuit claims that Apple misstated the timeline for integrating advanced AI-based Siri features, which were unlikely to be available for the iPhone 16, potentially harming sales [5]. - Investors are encouraged to join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Legal Representation - The Rosen Law Firm, known for its success in securities class actions, is representing the investors and has a strong track record in recovering funds for clients [4]. - Investors can join the class action by submitting a form or contacting the law firm directly [3][6]. - No class has been certified yet, meaning investors are not represented unless they retain counsel [7].

Core Viewpoint - Compass Diversified (NYSE: CODI) has issued a warning to investors regarding the unreliability of its financial statements for the fiscal years ending December 31, 2022 and 2023 due to expanded accounting irregularities [1][5]. Group 1: Financial Irregularities - The company disclosed that accounting irregularities at its subsidiary, Lugano Holding, have affected financial statements not only for 2024 but also for the fiscal years 2022 and 2023 [4][5]. - Investors are advised to no longer rely on the annual and quarterly financial statements for these years [5]. Group 2: Legal Actions - A class-action lawsuit has been filed against Compass Diversified, seeking to represent investors who purchased its publicly traded securities from February 24, 2022, to May 7, 2025 [3][4]. - The lawsuit alleges that the company made false and misleading statements while failing to disclose critical information regarding its financial practices [6]. Group 3: Market Reaction - Following the announcement of the accounting irregularities, Compass Diversified's stock price fell by more than 62% [7]. Group 4: Internal Controls and Oversight - The company has been criticized for neglecting to implement effective internal controls over its financial reporting, leading to materially misstated financial results [9]. - The issues at Lugano suggest a failure of oversight by Compass Diversified, indicating a deeper problem within the subsidiary [10].

Core Viewpoint - Hims & Hers Health, Inc. is facing two securities class action lawsuits following the termination of its collaboration with Novo Nordisk due to concerns over deceptive marketing practices related to the weight loss drug Wegovy® [1][2][4]. Group 1: Lawsuits and Allegations - The lawsuits, filed on June 25, 2025, seek to represent investors who acquired Hims & Hers securities between April 29, 2025, and June 23, 2025 [1][3]. - Allegations include that Hims & Hers made false and misleading statements and failed to disclose critical information regarding the safety of its products and the legality of its marketing practices [4][5]. - The termination of the collaboration with Novo Nordisk was announced on June 23, 2025, citing concerns over illegal mass compounding and deceptive marketing practices that jeopardized patient safety [5]. Group 2: Impact on Share Price - Following the announcement of the termination, Hims & Hers shares experienced a significant decline, crashing by 30% [2]. Group 3: Investigation and Legal Support - Hagens Berman, a national shareholders rights firm, is investigating the claims and encourages affected investors to report their losses [3][6]. - The firm is also seeking information from individuals who may assist in the investigation, highlighting the potential for whistleblower rewards under the SEC Whistleblower program [6].